Karuna Therapeutics Inc
KRTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.6B
Close$
$4.56
98.6% downside
Current Fair Value
98.6% downsideOvervalued by 98.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.60 Billion |
|---|---|
| Enterprise Value | $12.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.73 |
| Beta | 1.15 |
| Outstanding Shares | 37,780,998 |
Return
| Return on Equity | -33.66% |
|---|---|
| Return on Assets | -31.60% |
| Return on Invested Capital | -39.12% |
Valuation & Multiples
| P/E Ratio | -28.12 |
|---|---|
| PEG | -56.98 |
| Price to Sales | - |
| Price to Book Ratio | 9.99 |
| Enterprise Value to Revenue | 19069.95 |
| Enterprise Value to EBIT | -25.14 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data